CenExel Clinical Research

CenExel Clinical Research

CenExel Clinical Research is a network of clinical trial sites and a contract research organization (CRO) headquartered in Salt Lake City, Utah. The firm was established to centralize clinical trial operations across multiple U.S. research sites, serving pharmaceutical and biotech sponsors in need of patient recruitment and trial execution. Its legal structure and ownership details are not publicly disclosed. The organization conducts Phase I through Phase IV clinical studies across therapeutic areas including central nervous system (CNS), pain management, psychiatry, and internal medicine. CenExel operates research sites in states including Utah, Texas, California, and Florida. The company markets itself as providing rapid patient enrollment and high-throughput data collection for sponsors seeking to accelerate drug development timelines. CenExel's scale is reflected in its network of individual clinical research sites, which are each capable of conducting multiple simultaneous studies. The company does not publicly disclose staff counts or financial metrics in its marketing materials or public communications. No recent operational events (within 24 months) have been independently reported by major publications. As a clinical trial site network, CenExel's structural differentiator is its geographic distribution of research centers — allowing sponsors to run multi-site trials under a single operational umbrella. This contrasts with traditional CROs that manage trials through contract agreements with independent sites. The company's revenue model is based on per-study service fees rather than asset management, which places it outside the family office or asset manager category.